NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 156.60K | 172.20K | 159.70K | 159.80K | 160.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 159.60K | 179.80K | 168.80K | 181.50K | 186.50K |
| Operating Income | -159.60K | -179.80K | -168.80K | -181.50K | -186.50K |
| Income Before Tax | 252.70K | 207.40K | 263.30K | -199.00K | -198.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.25 | 0.21 | 0.26 | -0.20 | -0.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 252.70K | 207.40K | 263.30K | -199.00K | -198.80K |
| EBIT | -159.60K | -179.80K | -168.80K | -181.50K | -186.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.02 | 0.02 | 0.03 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.02 | 0.02 | 0.03 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 41.10M | 41.10M | 41.10M | 41.10M | 41.10M |
| Average Diluted Shares Outstanding | 41.10M | 41.10M | 41.10M | 41.10M | 41.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |